Showing 31-40 of 3289 results for "".
DermWireTV: Cosentyx for Kids; Anifrolumab for SLE, Tremfya in PsA at EULAR
https://practicaldermatology.com/topics/psoriasis/dermwiretv-cosentyx-for-kids-anifrolumab-for-sle-tremfya-in-psa-at-eular/19948/FDA has approved Cosentyx (secukinumab) from Novartis for patients as young as six years old. The 2nd Annual San Diego Dermatology Symposium kicks off as a live Virtual Experience next Friday. A post-hoc analysis of pooled data from the TULIP Phase 3 clinical trials shows that anifrolumab improvesDermWireTV: Candela + Merz Aesthetics Partnership, COVID-19 Vaccines & Fillers, Almirall's Klisyri, MetSyn & PsO
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-candela-merz-aesthetics-partnership-covid-19-vaccines-and-fillers-almiralls-klisyri-metsyn-and-pso/19893/Klisyri® (tirbanibulin) ointment 1% from Almirall will be available for treatment of AKs by the end of this quarter; Ayman Grada, MD discusses. Are patients who have received dermal filler injections at risk for developing reactions to the COVID-19 vaccine? Joel L. Cohen, MD and Doris Day, MD weighDERM2020 Content Recap: Kristine Kucera, PA-C
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-content-recap-kristine-kucera-pa-c/19842/DERM2020 Faculty Kristine Kucera, PA-C covers her thoughts on the case presentations during DERM2020.Effective Patient Consultations: Keys to Success
https://practicaldermatology.com/topics/practice-management/effective-patient-consultations-keys-to-success/20122/So much depends on the patient consultation, and its key that all members of the practice staff are attentive to the needs of the patient and the practice. Amy Lewis, MD and Mark Rubin, MD weigh in on strategies for effective patient interactions.Update on Keloids and Scarring
https://practicaldermatology.com/topics/general-topics/update-on-keloids-and-scarring/19267/Brian Berman, MD talks with host Joshua Zeichner, MD about the use of interferon and topical immune modulators for the management of keloids. What does the evidence show? What are optimal protocols?ASDS Quest Keeps Members In the Know
https://practicaldermatology.com/topics/practice-management/asds-quest-keeps-members-in-the-know/18320/Quest is the American Society for Dermatologic Surgery's digital knowledge network, and it allows members to discuss difficult cases, share tips and interact with one another. Dr. Cox discusses all of the perks of Quest with host Joel Cohen, MD.Superficial Radiation for Keloids: SRT-100 in Practice
https://practicaldermatology.com/topics/skin-cancer-photoprotection/superficial-radiation-for-keloids-srt-100-in-practice/19040/Keloids are common. Certain patients, especially patients of color, are more prone to the development of keloids in certain locations, especially areas such as the chest, back, and other areas. Most studies that show that keloids can occur in up to 90 percent of cases when they're excised. The use o2014 Year in Review: Actinic Keratosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/2014-year-in-review-actinic-keratosis/19003/Neal Bhatia, MD discusses the management of actinic keratosis in 2014. He also offers a look at what's ahead for the specialty as a whole in 2015.SDPA: Medical Director Dr. Hilary Baldwin Discusses Acne and Keloids Lectures
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-discusses-acne-and-keloids-lectures/29508/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. She explains the key takeaways of her lectures on acne and keloids.RF Technologies: What should you know?
https://practicaldermatology.com/series/scientifically-speaking/rf-technologies-what-should-you-know/19848/With so many radiofrequency devices now on the market and new ones in development, aesthetic specialists need to know how to select the proper tool for each patient need. E. Victor Ross, MD and Erez Dayan, MD join host Joel L. Cohen, MD to go beyond the marketing jargon to assess the science and cli